ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0543

Novel Insights into Systemic Sclerosis Using a Sensitive Computational Method to Analyze Whole-genome Bisulfite Sequencing Data

Jeffrey Yu1, Tianyuan Lu1, Kaiqiong Zhao1, Kathleen Oros Klein1, Maximilien Lora2, Ines Colmegna3, Celia MT Greenwood4 and Marie Hudson2, 1Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC, Canada, 2McGill University, Montréal, QC, Canada, 3The Research Institute of the McGill University Health Centre, Montréal, QC, Canada, 4Epidemiology, Biostatistics and Occupational Health / Faculty of Medicine and Health Sciences / McGill University, Montréal, QC, Canada

Meeting: ACR Convergence 2021

Keywords: Epigenetics, Statistical methods, Systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 7, 2021

Title: Systemic Sclerosis & Related Disorders – Basic Science Poster (0541–0559)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: While the etiology of systemic sclerosis (SSc) remains largely unknown, epigenetic dysregulation including abnormal DNA methylation is thought to contribute to its onset and progression. Currently, the most comprehensive assay for profiling DNA methylation is whole-genome bisulfite sequencing (WGBS), but its precision depends on read depth and it may be subject to sequencing errors. SOMNiBUS (Zhao et al. 2020) was developed to overcome some of these limitations. This one-stage method infers smooth covariate effects across regions while accounting for variable read depth, missing data patterns, sequencing errors, and confounders such as age. Using SOMNiBUS, we reanalyzed WGBS data on SSc patients and controls initially analyzed using bumphunter (Jaffe et al. 2012, Aryee et al. 2014, Lu et al., 2019), a less sensitive two-stage approach that fits single CpG associations first, followed by separate coefficient smoothing based on the fitted associations. We aimed to identify novel regions of dysregulated DNA methylation, thus providing a more comprehensive understanding of SSc pathogenesis.

Methods: Purified CD4+ T lymphocytes for 9 SSc and 4 control females were sequenced using WGBS. We separated the resulting sequence into regions with cuts made when adjacent CpG sites were spaced more than 200 bp apart. 8268 regions containing ≥ 60 CpGs were retained for analysis. DMRs were inferred with SOMNiBUS region-level test, adjusted for age. Pathway enrichment analysis was performed with Ingenuity Pathway Analysis (IPA) for genes with DMRs located on the gene body or within regulatory regions. We compared the results to those obtained by bumphunter in terms of plausibility of enriched pathways and agreement in genes detected.

Results: We identified more DMRs with SOMNIBUS compared to bumphunter for both significance levels tested (Fig. 1 & Table 1). We selected all DMRs with a suggestive association defined by regional significance ≤ 1e-5 that overlapped either with a gene body or with the region 10,000 bp upstream of its transcription start site, allowing us to annotate DMRs up to the distal regulatory region (DRR), resulting in 161 differentially methylated genes (DMGs; Table 2). Changing the regional significance threshold to ≤ 0.05 for DMRs, we obtained 1,440 DMGs for SOMNiBUS compared to 340 DMGs for bumphunter (Table 1), 77 of which were identified by both methods. SOMNiBUS detected 29% of bumphunter’s DMGs with DMRs of < 60 CpGs, along with 22% of bumphunter’s other DMGs. In analyses stratified by autosomal and X chromosomes, the top-ranked autosomal gene was FLT4, a lymphangiogenic orchestrator previously associated with SSc (Manetti et al., 2019); 52 genes were identified on the X-chromosome (Table 2). IPA identified 10 enriched pathways for autosomal chromosomes with cell cycling as the top-ranked pathway and 5 enriched pathways for chromosomes X with antigen presentation as the top-ranked pathway (Table 2).

Conclusion: Using a novel and more powerful computational approach, we identified new and biologically plausible regions of the genome associated with SSc. These findings deepen biological insights into SSc and provide novel avenues of investigation into its pathogenesis.


Disclosures: J. Yu, None; T. Lu, None; K. Zhao, None; K. Klein, None; M. Lora, None; I. Colmegna, None; C. Greenwood, None; M. Hudson, None.

To cite this abstract in AMA style:

Yu J, Lu T, Zhao K, Klein K, Lora M, Colmegna I, Greenwood C, Hudson M. Novel Insights into Systemic Sclerosis Using a Sensitive Computational Method to Analyze Whole-genome Bisulfite Sequencing Data [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/novel-insights-into-systemic-sclerosis-using-a-sensitive-computational-method-to-analyze-whole-genome-bisulfite-sequencing-data/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/novel-insights-into-systemic-sclerosis-using-a-sensitive-computational-method-to-analyze-whole-genome-bisulfite-sequencing-data/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology